Filings buzz in pharmaceuticals: 3Q21 sees a 20% decrease in digitalization mentions
Still, pharma companies mentioned digitalization in their filings 421% more often in 3Q21 than in the same quarter in 2016
ByDashboard Featured
Future of work hiring levels in the pharmaceutical industry rose in November 2021
In November 2021, 3.6% of newly posted job advertisements were future of work-related job opportunities
By
Filings buzz in pharmaceuticals: 34% decrease in industrial automation mentions in Q2 of 2021
Of the 50 biggest employers in pharma, Lonza Group referred to industrial automation the most between July 2020 and June…
By
Pfizer acquires Amplyx Pharmaceuticals to advance anti-infectives pipeline
Pfizer has acquired US-based Amplyx Pharmaceuticals to advance its expertise in infectious disease and expand its anti-infectives pipeline.
Science park merger creates UK’s largest life sciences ecosystem
Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in…
By
Vertex and Obsidian enter agreement to develop gene-editing treatments
Vertex Pharmaceuticals (VRTX) and Obsidian Therapeutics have entered a strategic research partnership and licensing agreement to discover and develop novel…
Janux Therapeutics raises funding to advance T cell engager treatments
Janux Therapeutics has raised $125m through a series B funding round to advance its pipeline of next-generation T cell engager…
AZ’s proposed acquisition of rare disease-focused Alexion gets US clearance
AstraZeneca’s proposed $39bn acquisition of rare disease therapy company Alexion Pharmaceuticals has passed a US Federal Trade Commission review.
By